Cytosorbents (CTSO) Capital Expenditures (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -89.81% |
| Dec 31, 2025 | 535.29% |
| Sep 30, 2025 | -54.05% |
| Jun 30, 2025 | 1,750.00% |
| Mar 31, 2025 | -97.10% |
| Dec 31, 2024 | -54.61% |
| Sep 30, 2024 | 753.50% |
| Jun 30, 2024 | -60.59% |
| Mar 31, 2024 | -52.68% |
| Dec 31, 2023 | -32.94% |
| Sep 30, 2023 | -52.57% |
| Dec 31, 2022 | 217.22% |
| Sep 30, 2022 | -259.86% |
| Jun 30, 2022 | 45.10% |
| Mar 31, 2022 | -41.35% |
| Dec 31, 2021 | 399.14% |
| Sep 30, 2021 | -254.35% |
| Jun 30, 2021 | 83.98% |
| Mar 31, 2021 | 164.58% |
| Dec 31, 2020 | -29.53% |
| Sep 30, 2020 | 183.94% |
| Jun 30, 2020 | -65.63% |
| Mar 31, 2020 | 67.35% |
| Dec 31, 2019 | 11.38% |
| Sep 30, 2019 | -8.81% |
| Jun 30, 2019 | -52.61% |
| Mar 31, 2019 | 65.75% |
| Dec 31, 2018 | 553.54% |
| Sep 30, 2018 | -88.03% |
| Jun 30, 2018 | -7.18% |
| Mar 31, 2018 | -40.84% |
| Dec 31, 2017 | 17.24% |
| Sep 30, 2017 | 120.82% |
| Jun 30, 2017 | 123.54% |
| Mar 31, 2017 | 574.02% |
| Dec 31, 2016 | -126.10% |
| Sep 30, 2016 | -8.24% |
| Jun 30, 2016 | 74.58% |
| Mar 31, 2016 | -66.61% |
| Dec 31, 2015 | 3.31% |
| Sep 30, 2015 | 17.23% |
| Jun 30, 2015 | -14.86% |
| Mar 31, 2015 | 63.37% |
| Dec 31, 2014 | 83.14% |
| Sep 30, 2014 | 4.19% |
| Jun 30, 2014 | 56.13% |
| Mar 31, 2014 | 295.16% |
| Dec 31, 2013 | -49.59% |
| Sep 30, 2013 | -47.32% |
| Jun 30, 2013 | 831.52% |
| Mar 31, 2013 | -88.99% |
| Dec 31, 2012 | 1,963.85% |
| Dec 31, 2011 | -96.74% |